Bristol-Myers Squibb Global Patient Safety
GPTKB entity
Properties (63)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Department
|
gptkbp:analyzes |
Clinical trial data
Safety data Safety reports Trends in adverse events |
gptkbp:collaboratesWith |
Regulatory bodies
External partners Healthcare_professionals |
gptkbp:conducts |
Safety audits
Risk assessments Safety assessments Safety evaluations Post-marketing surveillance Safety training sessions Investigations of safety issues |
gptkbp:coordinatesWith |
Other departments
|
gptkbp:develops |
Safety protocols
Training materials Standard operating procedures Quality assurance processes Patient education materials Incident reporting systems Crisis management plans Safety management plans |
gptkbp:engagesIn |
Stakeholder engagement
Public health initiatives Risk communication |
gptkbp:ensures |
Data integrity
Regulatory requirements Compliance with guidelines Patient confidentiality Patient safety compliance |
gptkbp:facilitates |
Safety meetings
|
gptkbp:focusesOn |
Patient safety
|
https://www.w3.org/2000/01/rdf-schema#label |
Bristol-Myers Squibb Global Patient Safety
|
gptkbp:implements |
Risk management strategies
|
gptkbp:maintains |
Documentation standards
|
gptkbp:manages |
Safety databases
|
gptkbp:monitors |
Product safety
Drug safety Adverse drug reactions Safety signals Compliance metrics |
gptkbp:participatesIn |
Safety committees
Regulatory inspections |
gptkbp:partOf |
gptkb:Bristol-Myers_Squibb
|
gptkbp:provides |
Risk assessment tools
Consultation services Safety training Safety information Expert advice Safety updates Feedback to stakeholders Guidance on safety issues |
gptkbp:providesSupportFor |
Clinical trials
|
gptkbp:railwayLine |
Staff members
|
gptkbp:reportsTo |
Regulatory agencies
|
gptkbp:responsibleFor |
Monitoring adverse events
|
gptkbp:reviews |
Clinical study reports
|
gptkbp:supports |
Patient safety initiatives
Regulatory submissions Pharmacovigilance activities |
gptkbp:utilizes |
Data analysis
|